Sweden - Uppsala First Wave COVID-19 ICU Patient Cohort Admitted Mar-Aug 2020, 3-6 Month Follow-up Sept-Nov 2020
Survey:
Health facility - Individual - Interview - Longitudinal
Pulmonary arterial hypertension
Dataset Records for Pulmonary arterial hypertension
Displaying 1 - 50 of 149
Austria - Tirol Neurological Outcome and Quality of Life Three Months After COVID-19 Prospective Observational Cohort Study 2020
Survey:
Exam - Individual - Interview
Honduras Multiple Indicator Cluster Survey 2019
Encuesta Nacional De Demografía Y Salud / Encuesta De Indicadores Múltiples Por Conglomerados (ENDESA/MICS 2019)
Survey:
Community - Cross-sectional - De jure - Household - Individual - Interview - Nationally representative - Subnationally representative - Urban-rural representative
South Africa Vital Registration - Causes of Death 2018
COD1997_2018
Vital registration:
Subnationally representative
High geographic prevalence of pulmonary artery hypertension: associations with ethnicity, drug use, and altitude
GHDx Entry last modified on: Jan 31, 2024
Incidence and prevalence of pulmonary arterial hypertension in Germany
GHDx Entry last modified on: May 30, 2020
Pulmonary arterial hypertension in Russia: six-year observation analysis of the National Registry
GHDx Entry last modified on: May 30, 2020
Survival of Idiopathic Pulmonary Arterial Hypertension Patients in the Modern Era in Australia and New Zealand
GHDx Entry last modified on: Jan 8, 2024
The causes, treatment, and outcome of pulmonary hypertension in Africa: Insights from the Pan African Pulmonary Hypertension Cohort (PAPUCO) Registry
GHDx Entry last modified on: May 30, 2020
The Characteristics of Treated Pulmonary Arterial Hypertension Patients in Ontario
GHDx Entry last modified on: May 30, 2020
Togo Health Statistics Yearbook 2020
Annuaires Des Statistiques Sanitaires Du Togo, Année 2020
Report:
Discharge - Epi surveillance - Inpatient - Outpatient - Subnationally representative
[Severe right ventricular dysfunction by echocardiography in pulmonary arterial hypertension: prevalence, clinical predictors, echocardiograph and treatment]
Disfunción grave de ventrículo derecho por ecocardiografía en hipertensión arterial pulmonar: prevalencia, predictores clínicos, ecocardiográficos y tratamiento
An observational study of inhaled-treprostinil respiratory-related safety in patients with pulmonary arterial hypertension
GHDx Entry last modified on: May 30, 2020
Survival of patients with schistosomiasis-associated pulmonary arterial hypertension in the modern management era
GHDx Entry last modified on: Jan 31, 2024
Pulmonary arterial hypertension in the USA: an epidemiological study in a large insured pediatric population
GHDx Entry last modified on: May 30, 2020
Real-world, long-term survival of incident patients with pulmonary arterial hypertension
GHDx Entry last modified on: May 30, 2020
Right ventricular sex differences in patients with idiopathic pulmonary arterial hypertension characterised by magnetic resonance imaging: pair-matched case controlled study
GHDx Entry last modified on: Apr 23, 2021
Survival and quality of life in incident systemic sclerosis-related pulmonary arterial hypertension
GHDx Entry last modified on: Jul 20, 2021
Pulmonary arterial hypertension in Saudi Arabia: patients' clinical and physiological characteristics and hemodynamic parameters. A single center experience
GHDx Entry last modified on: May 30, 2020
A simple hemodynamic parameter to predict clinical worsening in pulmonary arterial hypertension
GHDx Entry last modified on: May 30, 2020
Right isovolumic contraction velocity predicts survival in pulmonary hypertension
GHDx Entry last modified on: Jul 20, 2021
Iranian Pulmonary Arterial Hypertension Registry
GHDx Entry last modified on: May 30, 2020
Saudi experience in the management of pulmonary arterial hypertension; the outcome of PAH therapy with the exclusion of chronic parenteral prostacyclin
GHDx Entry last modified on: May 30, 2020
Prognostic relevance of right heart reverse remodeling in idiopathic pulmonary arterial hypertension
GHDx Entry last modified on: Jan 31, 2024
The Giessen Pulmonary Hypertension Registry: Survival in pulmonary hypertension subgroups
GHDx Entry last modified on: May 30, 2020
Baseline Characteristics of the Korean Registry of Pulmonary Arterial Hypertension
GHDx Entry last modified on: May 30, 2020
Impact of age and comorbidity on risk stratification in idiopathic pulmonary arterial hypertension
GHDx Entry last modified on: May 30, 2020
Pulmonary hypertension associated with rheumatic diseases: baseline characteristics from the Korean registry
GHDx Entry last modified on: May 30, 2020
Cape Verde Statistical Report 2017
Relatório Estatístico 2017
Report:
Epi surveillance - Financial - Subnationally representative
Current status of pulmonary arterial hypertension in Korea
GHDx Entry last modified on: May 30, 2020
Effectiveness and Outcome of Pulmonary Arterial Hypertension-Specific Therapy in Japanese Patients With Pulmonary Arterial Hypertension
GHDx Entry last modified on: May 30, 2020
Pulmonary arterial hypertension in the southern hemisphere: results from a registry of incident Brazilian cases
GHDx Entry last modified on: Jan 11, 2024
Pulmonary hypertension in Portugal: first data from a nationwide registry
GHDx Entry last modified on: May 30, 2020
Lower socioeconomic status is associated with worse outcomes in pulmonary arterial hypertension
GHDx Entry last modified on: Jan 31, 2024
Survival of Chinese patients with pulmonary arterial hypertension in the modern treatment era
GHDx Entry last modified on: May 30, 2020
Prevalence of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension in the United States
GHDx Entry last modified on: May 30, 2020
Follow-up tricuspid annular plane systolic excursion predicts survival in pulmonary arterial hypertension
GHDx Entry last modified on: Jan 31, 2024
Survival advantages of excess body mass index in patients with idiopathic pulmonary arterial hypertension
GHDx Entry last modified on: Jan 31, 2024
Clinical characteristics and survival of pulmonary arterial hypertension associated with three major connective tissue diseases: A cohort study in China
GHDx Entry last modified on: Jan 31, 2024
Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry
GHDx Entry last modified on: May 30, 2020
Survival in childhood pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management
GHDx Entry last modified on: May 30, 2020
Four- and seven-year outcomes of patients with congenital heart disease-associated pulmonary arterial hypertension (from the REVEAL Registry)
GHDx Entry last modified on: May 30, 2020
Survival in systemic sclerosis-associated pulmonary arterial hypertension in the modern management era
GHDx Entry last modified on: May 30, 2020
Connective tissue disease-associated pulmonary arterial hypertension in Chinese patients
GHDx Entry last modified on: Jul 20, 2021
Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension
GHDx Entry last modified on: May 30, 2020
Five-Year outcomes of patients enrolled in the REVEAL Registry
GHDx Entry last modified on: May 30, 2020
The changing picture of patients with pulmonary arterial hypertension in the United States: how REVEAL differs from historic and non-US Contemporary Registries
GHDx Entry last modified on: May 30, 2020
Sex differences in the diagnosis, treatment, and outcome of patients with pulmonary arterial hypertension enrolled in the registry to evaluate early and long-term pulmonary arterial hypertension disease management
GHDx Entry last modified on: May 30, 2020
REVEAL: a contemporary US pulmonary arterial hypertension registry
GHDx Entry last modified on: May 30, 2020
Subscribe